Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

KRYS

Krystal Biotech, Inc.

Healthcare · USD

Set alert

Price alert · KRYS

All alert types
332.29 USD +7.74 +2.38%
As of Oct 30, 2026 Extended hours 328.00 -1.29%
Bid
331.30 × 2
Ask
332.62 × 2
319.95 Day range 332.63
189.08 52-week range 378.15
YTD
+34.78%
1 year
+75.74%
Open
325.83
Prev close
324.55
Mkt cap
9.84B
Vol
330.31K
Avg vol
274.83K
EPS
7.98
P/E
41.64
Div yield
0.00%
More statistics
Low
319.95
High
332.63
Forward P/E
37.12
Beta
0.50
Short ratio
9.85
Inst. own
102.62%
Dividend
0.00
Ex-div date
Earnings
Nov 2, 2026
50-d avg
337.56
200-d avg
308.33
1y target
395.44

5D chart

Chart tools
Interval
1m5m15m30m
KRYS five-day price chart309.6315.3321.0326.7332.4Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

43.33 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E 34.8×
FY 2016: -39.4×FY 2017: -7.1×FY 2018: -21.4×FY 2019: -46.2×FY 2020: -35.1×FY 2021: -22.3×FY 2022: -14.4×FY 2023: 310×FY 2024: 50.2×FY 2025: 34.8×
FY 2016 5y median 34.8× FY 2025
P/S 18.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 227×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 66.4×FY 2024: 15.4×FY 2025: 18.3×
FY 2016 5y median 15.4× FY 2025
P/B 5.9×
FY 2016: 157×FY 2017: 1.1×FY 2018: 2.1×FY 2019: 4.3×FY 2020: 3.9×FY 2021: 2.6×FY 2022: 3.9×FY 2023: 4.3×FY 2024: 4.7×FY 2025: 5.9×
FY 2016 5y median 4.3× FY 2025
P/FCF 37.8×
FY 2016: -34.3×FY 2017: -13.8×FY 2018: -19.9×FY 2019: -35.1×FY 2020: -27.5×FY 2021: -13.4×FY 2022: -13.2×FY 2023: -33.5×FY 2024: 37.6×FY 2025: 37.8×
FY 2016 5y median -13.2× FY 2025
EV/EBITDA 33.9×
FY 2016: -39.8×FY 2017: -1.5×FY 2018: -12.0×FY 2019: -38.4×FY 2020: -28.7×FY 2021: -18.7×FY 2022: -16.1×FY 2023: -32.7×FY 2024: 37.7×FY 2025: 33.9×
FY 2016 5y median -16.1× FY 2025
EV/Sales 17.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 126×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 59.5×FY 2024: 14.3×FY 2025: 17.1×
FY 2016 5y median 14.3× FY 2025
FCF Yield 2.6%
FY 2016: -2.9%FY 2017: -7.3%FY 2018: -5.0%FY 2019: -2.9%FY 2020: -3.6%FY 2021: -7.5%FY 2022: -7.6%FY 2023: -3.0%FY 2024: 2.7%FY 2025: 2.6%
FY 2016 5y median -3.0% FY 2025

Profitability

Gross Margin 92.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 86.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 93.9%FY 2024: 93.1%FY 2025: 92.6%
FY 2016 5y median 92.6% FY 2025
Operating Margin 41.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -1160.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -216.4%FY 2024: 22.6%FY 2025: 41.5%
FY 2016 5y median 0.0% FY 2025
Net Margin 52.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -1060.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 21.6%FY 2024: 30.7%FY 2025: 52.6%
FY 2016 5y median 21.6% FY 2025
ROE 16.8%
FY 2016: -397.9%FY 2017: -16.0%FY 2018: -9.6%FY 2019: -9.4%FY 2020: -11.0%FY 2021: -11.7%FY 2022: -26.8%FY 2023: 1.4%FY 2024: 9.4%FY 2025: 16.8%
FY 2016 5y median 1.4% FY 2025
ROIC 13.1%
FY 2016: -53.4%FY 2017: -9.6%FY 2018: -10.5%FY 2019: -10.7%FY 2020: -10.9%FY 2021: -11.3%FY 2022: -27.3%FY 2023: -11.8%FY 2024: 6.4%FY 2025: 13.1%
FY 2016 5y median -11.3% FY 2025
ROA 15.4%
FY 2016: -52.7%FY 2017: -15.8%FY 2018: -9.4%FY 2019: -9.1%FY 2020: -10.3%FY 2021: -11.1%FY 2022: -25.1%FY 2023: 1.3%FY 2024: 8.4%FY 2025: 15.4%
FY 2016 5y median 1.3% FY 2025

Growth (YoY)

Revenue 33.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 473.0%FY 2025: 33.9%
FY 2016 FY 2025
Operating Income 145.5%
FY 2016: 0.0%FY 2017: -317.5%FY 2018: -149.7%FY 2019: -85.3%FY 2020: -49.4%FY 2021: -106.9%FY 2022: -112.7%FY 2023: 24.4%FY 2024: 159.9%FY 2025: 145.5%
FY 2016 FY 2025
EPS (diluted) 128.0%
FY 2016: 0.0%FY 2017: -448.1%FY 2018: 34.5%FY 2019: -23.7%FY 2020: -42.5%FY 2021: -83.0%FY 2022: -75.4%FY 2023: 107.1%FY 2024: 669.2%FY 2025: 128.0%
FY 2016 FY 2025
Free Cash Flow 58.5%
FY 2016: 0.0%FY 2017: -209.2%FY 2018: -184.9%FY 2019: -115.0%FY 2020: -63.0%FY 2021: -184.1%FY 2022: -32.1%FY 2023: 34.5%FY 2024: 218.5%FY 2025: 58.5%
FY 2016 FY 2025

Financial Health

Current Ratio 10.0×
FY 2016: 50.4×FY 2017: 78.0×FY 2018: 43.4×FY 2019: 58.9×FY 2020: 17.8×FY 2021: 17.2×FY 2022: 13.3×FY 2023: 17.8×FY 2024: 7.3×FY 2025: 10.0×
FY 2016 5y median 13.3× FY 2025
Quick Ratio 9.6×
FY 2016: 50.4×FY 2017: 78.0×FY 2018: 43.4×FY 2019: 58.9×FY 2020: 17.8×FY 2021: 17.2×FY 2022: 13.3×FY 2023: 17.6×FY 2024: 7.0×FY 2025: 9.6×
FY 2016 5y median 13.3× FY 2025
Debt / Equity 0.0×
FY 2016: 6.4×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -2.5×
FY 2016: 0.1×FY 2017: 10.7×FY 2018: 9.6×FY 2019: 10.2×FY 2020: 8.5×FY 2021: 5.1×FY 2022: 1.3×FY 2023: 3.8×FY 2024: -3.1×FY 2025: -2.5×
FY 2016 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2016: -163×FY 2017: -1.5×FY 2018: -11.6×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -45.8×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31